AN OBSERVATION ON THE CURATIVE EFFECT OF CATGUT-EMBEDDING AT ACUPOINTS FOR TREATMENT OF 80 CASES OF LUMBAR MUSCLE STRAIN

In the present paper,the clinical curative effects of catgut embedding therapyand traditional acupuncture therapy for treatment of lumbar muscle strain were compared.The sameacupoints were used in both groups.Results showed that the effective rates were 100% and 92.5%respectively in 80 cases of the catgut embedding group and 40 cases of the acupuncture group.Therewas a significant difference between the two groups(P【0.005).It indicates that the catgut embed-ding therapy is an effective method for treatment of lumbar muscle strain.

腹针联合穴位埋线治疗单纯性肥胖患者的效果

目的:观察腹针联合穴位埋线治疗单纯性肥胖患者的效果。方法:选取2020年10月至2022年10月该院收治的120例单纯性肥胖患者进行前瞻性研究,按随机数字表法将其分为对照组和观察组各60例。对照组予以饮食-运动-行为干预,观察组在对照组基础上予以腹针联合穴位埋线治疗,比较两组临床疗效,治疗前后体质量、体质量指数(BMI)、体脂率、血脂指标[三酰甘油(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)]水平和中医证候积分。结果:观察组治疗总有效率为93.33%(56/60),高于对照组的80.00%(48/60),差异有统计学意义(P<0.05);治疗后,观察组体质量、BMI和体脂率均低于对照组,差异有统计学意义(P<0.05);治疗后,观察组TG、TC、LDL-C水平均低于对照组,差异有统计学意义(P<0.05);治疗后,两组中医证候积分均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05)。结论:在饮食-运动-行为干预基础上予以腹针联合穴位埋线治疗单纯性肥胖患者可提高治疗总有效率,降低体质量、BMI、体脂率、血脂指标水平和中医证候积分,效果优于单纯饮食-运动-行为干预。

温针灸与穴位埋线联合治疗儿童肥胖的效果研究

目的分析温针灸与穴位埋线联合治疗儿童肥胖的效果。方法选取肥胖儿童82例,使用随机数字表法分为研究组(n=41)与对照组(n=41)。对照组应用温针灸治疗,研究组在对照组基础上联合穴位埋线治疗。比较两组儿童的治疗效果、脂质水平及不良事件发生情况。结果研究组总有效率95.12%显著高于对照组的78.05%(P<0.05)。治疗后,研究组低密度脂蛋白胆固醇(2.85±0.52)mmol/L、总胆固醇(4.65±0.49)mmol/L与甘油三酯(1.00±0.60)mmol/L均低于对照组的(3.26±0.49)、(5.20±0.50)、(1.28±0.46)mmol/L,高密度脂蛋白胆固醇(1.36±0.35)mmol/L高于对照组的(1.09±0.30)mmol/L(P<0.05)。不良事件发生率比较中,两组结果未见差异性(P>0.05)。结论温针灸与穴位埋线联合治疗儿童肥胖效果显著,可有效调节脂质指标,安全性较佳,具有临床推广价值。

针灸领域应用纳米技术的现状及思考

此文阐明纳米技术在针灸中目前的应用和未来的潜力,分别从纳米技术结合针灸针、穴位贴敷与穴位注射、穴位埋线3个方面进行论述。首先,纳米技术与针具制作方面相结合研制出的纳米针灸传感针在实时检测活体活性分子方面提供了新的解决方案;其次,纳米中药与穴位注射、穴位贴敷等针灸特色疗法上的结合也具有很大的潜力;最后,依据纳米技术研发的高抗菌力、低过敏性的纳米银线,应用于临床,为临床穴位埋线治疗疾病提供更优的材料。但从纳米技术在针灸领域的应用现状来看,仍存在着一些待解决的问题,我们需要在不断思考中进一步探索,从而为今后临床治疗提供更多的选择。

心俞穴位埋线联合曲美他嗪对大鼠心肌梗死后能量代谢影响的研究

目的:观察心俞穴位埋线联合曲美他嗪对大鼠心肌梗死(MI)后能量代谢的影响。方法:以经典左前降支冠脉结扎术建立MI大鼠模型,将造模成功的大鼠随机分为模型组、埋线组、西药组、联合组,假手术组单开胸不结扎。术后第2天开始干预,并于术后7 d、28 d两个时间点观察。苏木精-伊红(HE)染色观察心肌组织病理形态;生化检测测定心肌组织ATP含量和血清中游离脂肪酸(FFA)浓度;Western blot法检测心肌组织AMPK、GLUT4蛋白表达。结果:与假手术组比较,术后7 d、28 d的模型组心肌细胞肿胀、排列紊乱并可见明显点状炎性细胞浸润,心肌细胞横截面积和血清FFA浓度增大、心肌ATP含量和AMPK、GLUT4蛋白表达降低(P<0.05)。术后7 d和28 d时,与模型组比较,3个治疗组的心肌细胞形态、排列及炎症细胞浸润程度均有不同程度的改善,心肌细胞横截面积和血清FFA浓度均不同程度减小、心肌ATP含量和AMPK、GLUT4蛋白表达均不同程度增加(P<0.05),其中联合组疗效比埋线组和西药组更明显(P<0.05)。与术后7 d的各治疗组比较,术后28 d各治疗组心肌ATP含量和AMPK、GLUT4蛋白表达均增大(均P<0.05),其中联合组的改善效应最明显(P<0.05)。结论:心俞穴位埋线联合曲美他嗪可进一步发挥对MI后心肌的保护作用,两者联合应用具有协同增效的作用,其作用机制可能是通过增加心肌组织AMPK和GLUT4蛋白的表达,可降低血清FFA浓度和增加心肌ATP含量来改善MI后心肌能量代谢紊乱,进而改善心肌细胞肥大,促进心肌损伤修复。

针刺、穴位埋线联合治疗过敏性鼻炎疗效及对炎症因子IL-4、IL-6、IL-10的影响

目的 研究针刺、穴位埋线联合治疗过敏性鼻炎的疗效及对炎症因子白介素-4(interleukin-4,IL-4),白介素-6(interleukin-6,IL-6),白介素-10(interleukin-10,IL-10)的影响。方法 选取2021年6月—2022年6月医院诊治的过敏性鼻炎患者106例作为研究对象,根据随机数字表法均分为两组,对照组53例、观察组53例。对照组进行穴位埋线治疗,观察组采用针刺、穴位埋线联合治疗。治疗4周后观察两组患者的疗效,炎症因子IL-4、IL-6、IL-10水平变化,生活质量以及不良反应情况。结果 观察组、对照组总有效率分别为98.11%、84.91%,观察组显著高于对照组,差异有统计学意义(P<0.05)。治疗前,两组患者炎症因子IL-4、IL-6、IL-10水平差异无统计学意义(P>0.05),治疗后,两组IL-4、IL-6水平均显著下降,IL-10水平显著升高差异有统计学意义(P<0.05),并且观察组IL-4、IL-6水平显著低于对照组,IL-10水平显著高于对照组差异有统计学意义(P<0.05)。治疗前两组鼻结膜炎生活质量调查问卷(rhinoconjunctivitis quality of life questionnaire, RQLQ)评分差异均无统计学意义(P>0.05),治疗后两组RQLQ各维度评分及总分均显著降低差异有统计学意义(P<0.05),且观察组RQLQ鼻部症状、眼部症状评分及总分显著低于对照组,差异有统计学意义(P<0.05)。观察组、对照组不良反应发生率分别为9.43%、5.66%,组间差异无统计学意义(P>0.05)。结论 针刺、穴位埋线联合治疗过敏性鼻炎的疗效显著,并且能够显著改善炎症因子水平及患者生活质量,同时保证良好的安全性,具有临床应用价值。

穴位埋线配合中药治疗非酒精性单纯性脂肪肝的疗效观察

目的 观察穴位埋线配合泽茵丸治疗非酒精性单纯性脂肪肝的临床疗效。方法 将124例非酒精性单纯性脂肪肝患者随机分为治疗组和对照组,每组62例。对照组采用口服奥利司他胶囊治疗,治疗组在对照组基础上加用穴位埋线配合口服泽茵丸治疗。观察两组治疗前后各项中医证候评分、肝脾CT比值、受控衰减参数(controlled attenuation parameter, CAP)值、体质量、腹围、身体质量指数(body mass index, BMI)及各项实验室指标[血清丙氨酸氨基转移酶(alanine aminotransferase, ALT)、总胆固醇(total cholesterol, TC)、甘油三酯(triglyceride, TG)水平]的变化情况,比较两组临床疗效。结果 治疗组治疗后愈显率为80.6%,明显高于对照组的54.8%(P<0.05)。两组治疗后各项中医证候评分、CAP值、体质量、腹围、BMI及TC、TG水平均较同组治疗前显著下降,肝脾CT比值均显著上升,差异均具有统计学意义(P<0.05)。治疗组治疗后部分中医证候评分(肝区不适或隐痛、形体肥胖、口苦评分及总分)、CAP值、体质量、腹围、BMI及TC、TG水平均明显低于对照组,肝脾CT比值明显高于对照组,差异均具有统计学意义(P<0.05)。结论 穴位埋线配合泽茵丸治疗非酒精性单纯性脂肪肝疗效确切,能显著升高肝脾CT比值,降低CAP值、体质量、腹围、BMI、TC、TG等指标。

中西结合穴位埋线提升联合易眼九美技术在面部、眼部年轻化中的应用

目的 观察中西结合穴位埋线提升联合易眼九美技术在面部、眼部年轻化中的应用。方法 选取2019年1月至2020年12月广西科学院大健康产业研究院抗衰中心收治的面部、眼部老化者180名,根据治疗方式不同将其分为三组,各60名。埋线组采用中西结合穴位埋线提升技术,易眼九美组采用易眼九美技术,联合组采用中西结合穴位埋线提升联合易眼九美技术。治疗前后的形态按照下颌缘形态标准、鼻唇沟形态标准及皱纹分级进行评分并比较,随后观察其治疗效果。结果 治疗后,三组鼻唇沟评分指标均低于治疗前,且联合组低于埋线组和易眼九美组(P<0.01);治疗后,三组下颌缘形态评分低于治疗前,且联合组低于埋线组和易眼九美组(P<0.01);治疗后,三组皱纹分级评分低于治疗前,且联合组低于埋线组和易眼九美组(P<0.01)。结论 中西结合穴位埋线提升联合易眼九美技术治疗面部老化的临床效果明显,采用逆向埋线提升技术即刻效果明显,远期疗效稳定,值得临床推广。

温针灸联合穴位埋线治疗糖尿病周围神经病变的效果分析

目的探究糖尿病周围神经病变患者在治疗期间选择温针灸联合穴位埋线治疗的效果。方法选取2022年1月—2023年6月山东德州陵城区人民医院康复医学科收治的106例糖尿病周围神经病变患者为研究对象,根据不同的治疗方法分为对照组和观察组,各53例。对照组实施常规治疗,观察组实施温针灸联合穴位埋线治疗,比较两组的神经传导速度[腓总神经感觉神经传导速度(sensory nerve conduction velocity,SCV)、腓总神经运动传导速度(motion conduction velocity,MCV)、正中神经MCV、正中神经SCV]、血流动力学(全血黏度、血浆比黏度、纤维蛋白原)、中医证候积分、不良反应发生率、临床疗效。结果观察组各项神经传导速度均高于对照组,差异有统计学意义(P均<0.05)。观察组各项血流动力学指标均低于对照组,差异有统计学意义(P均<0.05)。观察组中医证候积分低于对照组,差异有统计学意义(P<0.05)。观察组不良反应发生率低于对照组,差异有统计学意义(P<0.05)。观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05)。结论温针灸联合穴位埋线治疗糖尿病周围神经病变,可提高患者的神经传导速度,改善其血流动力学指标,降低其不良反应发生率,提高治疗有效率。

穴位埋线疗法治疗单纯性肥胖疗效观察

目的:观察穴位埋线治疗单纯性肥胖症的临床疗效。方法:将75例单纯性肥胖患者随机分为3组各25例。常规组予生活方式干预,西药组在常规组治疗的基础上予奥利司他胶囊口服,埋线组在常规组治疗基础上予穴位埋线治疗。观察3组治疗前后体质量、BMI、腰围、血清总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白(HDL-C)、低密度脂蛋白变化(LDL-C)水平,并比较3组临床疗效。结果:治疗后,各组患者体质量、BMI水平均低于治疗前(P﹤0.05);埋线组腰围低于治疗前,差异有统计学意义(P﹤0.05),且埋线组腰围低于常规组,差异有统计学意义(P﹤0.05)。治疗后,各组血脂水平与治疗前比较,差异有统计学意义(P﹤0.05);埋线组及西药组TG、TC水平均低于常规组,差异均有统计学意义(P﹤0.05)。结论:穴位埋线疗法配合生活方式干预治疗单纯性肥胖临床效果较好。

Acupoint catgut embedding versus acupuncture for simple obesity:a systematic review and Meta-analysis of randomized controlled trials

OBJECTIVE: To evaluate the clinical effectiveness and safety of acupoint catgut embedding and acupuncture on simple obesity by Meta-analysis. METHODS: Studies on clinical randomized controlled trials of acupoint catgut embedding for simple obesity which were published from January 2015 to November 2020 were searched in Cochrane Central Register of Control Trials(Central), Pub Med, China Science and Technology Journal Database, China National Knowledge Infrastructure Database and Wanfang databases. And those that met the inclusion criteria were screened. Rev Man5.3 was used for Meta-analysis. The “Risk of Bias” tool was used to evaluate the quality of included studies. R studio software was used for the measurement of publication bias. RESULTS: A total of 33 studies were included for Metaanalysis, including 2685 patients with simple obesity. Meta-analysis results showed the comparison of effectiveness rate was relative risk(RR) = 1.12, 95%CI(1.08, 1.16), body mass index(BMI) was mean difference(MD) =-1.12, 95%CI(-2.09,-0.14), waist circumference was MD =-2.14, 95%CI(-4.22,-0.06), and body mass was MD =-2.36, 95%CI(-3.99,-0.73). On the basis of diet and exercise intervention, the effectiveness rate [RR = 1.12, 95%CI(1.05, 1.19)], BMI [MD =-0.88, 95%CI(-1.35,-0.40)], waist circumference [MD =-1.10, 95%CI(-4.27, 2.07)], and body mass [MD =-0.68, 95%CI(-2.90, 1.54)]. The risk of bias of included literatures was low. CONCLUSIONS: Acupoint catgut embedding therapy was slightly better than acupuncture therapy in most of the outcomes. Moreover, the treatment frequency of acupoint catgut embedding is less with larger stimulation intensity, which is more conducive to clinical promotion.

Systematic review and Meta-analysis of acupuncture and acupoint catgut embedding for the treatment of abdominal obesity

OBJECTIVE:To systematically review and analyze the effect of acupuncture and acupoint catgut embedding in treatment of abdominal obesity to provide a more reasonable clinical treatment regimen.METHODS:Ten databases were searched as of August 2022:the English databases Pub Med,Embase,Cochrane Library,Web of Science,Wiley,and Scopus and the Chinese databases China National Knowledge Infrastructure Database,China Science and Technology Journal Database,Wanfang,and Sino Med/Chinese Biomedical Literature Database.Randomized controlled trials(RCTs)of acupuncture and acupoint catgut embedding as the main interventions to treat abdominal obesity were extracted.The investigators imported the citations into End Note version X9.1 for deduplication,screening,extraction,and integration.The risk of bias in the included RCTs was assessed according to the Cochrane Handbook.Rev Man 5.4 software was used to conduct a Meta-analysis of RCTs that met the inclusion criteria.RESULTS:Thirteen RCTs(1069 patients)were included in this study,and the data of eleven RCTs(966 patients)were include in the Meta-analysis.The results showed that acupoint catgut embedding can significantly change the weight and waist circumference of patients with abdominal obesity when compared to sham acupuncture or no treatment[mean difference(MD)=2.32,95%confidence interval(CI)(1.88,2.76),P<0.00001],[MD=3.47,95%CI(1.99,4.94),P<0.00001].The change in hip circumference after acupuncture was also significant[MD=0.89,95%CI(0.12,1.66),P=0.02].CONCLUSION:This study found that acupuncture and acupoint catgut embedding can effectively treat abdominal obesity,therefore,these interventions can be used as clinical supplements and alternative therapies.The diagnostic criteria of the existing studies and the intervention measures of the control group are not unified.It will be necessary to improve the clinical study protocols and expand the sample size to further validate the reliability of the results obtained of this study.

Advances in Acupuncture and its Associated Therapies for the Prevention and Treatment of Obesity Type 2 Diabetes Mellitus

Obesity type 2 diabetes mellitus is a common metabolic disease in clinical practice,and its prevalence is increasing rapidly with the aging of the population and changes in lifestyle.Acupuncture,as a distinctive therapy,has its unique advantages in the treatment of obesity type 2 diabetes and has an irreplaceable role in a variety of treatment methods.The author organized the literature on acupuncture and its related therapies to prevent and treat obesity type 2 diabetes in recent years and found that acupuncture and its associated therapies to prevent and treat obesity type 2 diabetes mainly include:simple acupuncture,electroacupuncture,acupoint catgut embedding therapy,auricular-plaster therapy and other treatments,all of which can safely and effectively improve clinical symptoms,acupuncture and its related therapies to treat obesity type 2 diabetes has a broad prospect,worthy of further clinical promotion.

温阳通络针灸法联合穴位埋线治疗小儿痉挛型脑瘫临床研究

目的:探究温阳通络针灸法配合穴位埋线治疗小儿痉挛型脑瘫的临床效果。方法:将68例痉挛型脑瘫患儿以随机数字表法分为两组,每组34例,对照组以常规西药治疗,在此基础上,治疗组以温阳通络针灸法配合穴位埋线治疗。比较两组临床疗效、运动功能、痉挛指数、脑血流动力学指标及智力情况。结果:治疗后治疗组总有效率高于对照组(P<0.05)。两组治疗前粗大运动功能测试量表(GMFM)、临床痉挛指数(CSI)量表评分比较差异无统计学意义(均P>0.05);两组治疗后GMFM评分升高,CSI评分降低,治疗组GMFM评分高于对照组,CSI评分低于对照组(均P<0.05)。两组治疗前血管搏动指数(PI)、血管阻力指数(RI)值比较差异无统计学意义(均P>0.05);两组治疗后RI、PI值均降低,治疗组低于对照组(均P<0.05)。两组治疗前语言发育能力、个人社交能力、社会适应能力DQ值比较差异无统计学意义(均P>0.05);两组治疗后DQ值提高,治疗组高于对照组(均P<0.05)。结论:采取温阳通络针灸法联合穴位埋线治疗小儿痉挛型脑瘫可有效改善患儿运动功能、痉挛程度、脑血流动力学指标及智力状况,从而提升临床疗效。

针灸治疗单纯性肥胖症的研究进展及机制探讨

针灸治疗单纯性肥胖症的方法包括:针刺疗法、电针疗法、穴位埋线、温针灸、拔罐法、针刺联合疗法等。针灸通过促进白色脂肪棕色化、调节肠道菌群、调节瘦素分泌、调节神经系统和内分泌等调控机体代谢,进而产生减重的治疗效应。目前,对于单纯性肥胖症的研究仍存在不足,一是对于针刺治疗单纯性肥胖症的操作手法如进针深度、补泻手法和行针手法的讨论研究样本较少,结论不充分;二是临床研究和机制研究多集中在电针和穴位埋线上,而拔罐、温针灸等临床研究及实验研究较少;三是缺乏长期随访。望今后开展更多的拔罐、温针灸等临床及实验研究,并且在未来研究中重视针刺治疗肥胖症操作手法的研究,在临床试验中进行长期随访,以验证针灸治疗的远期疗效。另外,预防及治疗超重/肥胖的首选方案仍是限制热量的摄入及增加热量的消耗,针灸治疗时嘱患者合理改善饮食方式及适当锻炼,更有利于减重。

毫火针联合穴位埋线治疗白癜风的疗效观察及对血清IL-2、IL-6水平的影响

目的观察毫火针联合穴位埋线治疗白癜风的临床疗效及对血清白介素-2(interleukin-2,IL-2)和白介素-6(interleukin-6,IL-6)水平的影响。方法将80例白癜风稳定期患者随机分为对照组和观察组,每组40例。对照组予以西医常规治疗(卤米松软膏和卡泊三醇软膏外擦及窄谱光紫外线治疗仪照射治疗),观察组在对照组治疗的基础上采用毫火针联合穴位埋线治疗。观察两组治疗前后皮损面积、血清IL-2和IL-6水平,并比较两组临床疗效及不良反应发生率。结果观察组的总有效率为92.5%,高于对照组的70.0%,差异有统计学意义(P<0.05)。治疗后,两组皮损面积均减少,且观察组皮损面积小于对照组,差异有统计学意义(P<0.05)。治疗后,两组血清IL-2水平升高,血清IL-6水平降低,差异有统计学意义(P<0.05);观察组血清IL-2水平高于对照组,血清IL-6水平低于对照组,差异有统计学意义(P<0.05)。两组不良反应发生率比较差异无统计学意义(P>0.05)。结论在西医常规治疗的基础上,毫火针联合穴位埋线治疗白癜风可明显减小皮损面积,升高血清IL-2水平,降低血清IL-6水平,安全性高。

中医特色疗法的抗衰老研究进展

中医药在养生抗衰、长寿延年方面积累了非常丰富的经验,“十四五”期间我国将大力发展中医药老年健康服务,培训推广中医适宜技术,提升中医药特色服务能力。现代研究发现针灸、按摩推拿、穴位埋线、拔罐、膏方等中医特色疗法都具有一定的抗衰老作用,其中针刺、艾灸的抗衰老效果主要体现在提高认知功能、提高免疫功能、改善生殖功能、提高骨密度、改善皮肤衰老等方面;穴位埋线除具有上述作用外,还可用于改善绝经后肥胖;推拿按摩可以提高免疫功能、提高骨密度、改善皮肤衰老;拔罐、膏方则主要体现在提高免疫功能和改善皮肤衰老。上述特色疗法和传统健身功法在临床应用中均可以改善老年人的衰老症状,提高生命质量。虽然相关研究较多,但大部分是药效动物实验,且存在低水平重复的问题,缺乏系统性、深入性、前沿性、创新性、针对性、多样性和权威性,高水平临床研究尤其缺乏,在方案设计、模型建立、指标选择、实验技术等方面亦有待提高,后续应加强中医特色疗法抗衰老的临床研究,完善评价指标体系,为健康中国贡献中医药力量。

中医药在高血压前期防治中的应用综述

中医药运用治未病理论,从整体出发,辨证运用中药方剂及非药物疗法,联合生活方式干预,降低血压,改善体质,保护靶器官,阻断高血压进程,具有综合调节的独特优势。但目前的研究尚存在一些问题:①缺乏客观的病机演变理论;②证候分型标准多依据个人临床经验制定,缺乏规范化的诊断标准;③随机对照试验较少,样本量小,观察周期短,循证医学证据不足。未来可进行以下研究:①建立数字化平台,整理挖掘古今文献,完善、总结高血压前期病因病机演变理论、中医证候分布特点;②增加专家的咨询调查和流行病学研究,建立规范的中医证型诊断标准,统计分析西医检查指标与中医证候的相关性,为临床辨证提供客观依据。③开展大样本、多中心、随机、双盲、对照试验,为中医药在高血压前期防治中的应用提供循证医学支持。

中医外治法治疗顽固性面瘫的研究进展

顽固性面瘫属于临床常见的顽固性疾病之一,其面部症状影响面部美观,严重影响患者的日常生活以及心理健康;而种种不良的心理、情志因素一定程度上也会影响治疗效果,因而形成恶性循环的不在少数。目前,用于治疗顽固性面瘫的中医外治法种类繁多,如针刺、艾灸、穴位注射、穴位埋线、推拿、拔罐等,其通常操作简便、绿色安全,治疗顽固性面瘫疗效明显且易于接受,同时其往往价格低廉,对患者的创伤较小,便于临床运用,易于向基层推广。现对近五年(2019-2023年)中医外治法治疗顽固性面瘫的相关文献进行筛选、整理、归纳,以期为临床治疗顽固性面瘫提供更多参考与依据。

Acupoint Catgut Embedding Alleviates Insomnia in Different Chinese Medicine Syndrome Types: A Randomized Controlled Trial

Objective: To investigate the effects and safety of catgut embedding on alleviating insomnia. Methods: Totally 510 patients with insomnia were divided into 5 Chinese medicine(CM) syndrome types: Xin(Heart) and Pi(Spleen) deficiency, yin deficiency with excess fire, Xin and gut qi deficiency, Wei(Stomach) disorder, and qi and blood deficiency, respectively. These 5 types of patients were randomly assigned to a catgut embedding group, an acupuncture group or a medication group(30 cases in Xin and Pi deficiency type, Wei disorder type, Xin and gut qi deficiency type, respectively;40 cases in yin deficiency with excess fire type and qi and blood deficiency type, respectively). In the catgut embedding group, patients were treated by implanting catgut into acupoints once every 10 days for a total of 30 days. In the acupuncture group, patients were treated with acupuncture once per day over 30 days(excluding weekends);and patients in the medication group took 1 mg Eurodin Tablet orally every night for 30 days. Pittsburgh Sleep Quality Index(PSQI) was evaluated before treatment, on 30 and 60 days after the first treatment, respectively. The International Unified Sleep Efficiency Value(IUSEV) was measured at 30 and 60 days. The safety was evaluated after treatment and adverse events were analyzed. Results: The objective PSQI scores including subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, daytime dysfunction, and total scores at 30 days were significantly improved compared with pre-treatment in the catgut embedding and acupuncture groups(P<0.01 or P<0.05). At 30 days, the PSQI scores in catgut embedding group were superior to the medication group in the patients with each type of insomnia, with the exception of sleep duration(P<0.01 or P<0.05). At 60 days, significant differences were found between the catgut embedding group and the medication group(P<0.01 for all indices). The IUSEV scores in the catgut embedding group were significantly higher than the acupuncture group at 60 days, and the scores in acupuncture group were higher than the medication group at 30 days(P<0.05 for all types). No severe adverse events were found in this study. Conclusions: Acupoint catgut embedding and acupuncture were more effective than medication in alleviating insomnia syndrome in different Chinese medicine syndrome type. However, the sustained effects of acupoint catgut embedding were superior to acupuncture.